---
schema_version: "secwatch.filing_event.v1"
accession: "0001847903-25-000093"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:49:36.784090+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Centessa shareholders approve all proposals at 2025 AGM, including director re-elections

## Summary
- Re-elected Arjun Goyal with 116.9M votes for, 463,793 against; Samarth Kulkarni with 97.7M for, 19.6M against.
- Approved KPMG LLP as UK statutory auditors and KPMG LLP (Delaware) as independent auditor for FY2025.
- Adopted UK statutory accounts for FY2024; no dividend recommended.
- Authorized directors to allot shares up to £133,184 nominal value under Companies Act.
- Special resolution passed to empower board to allot equity for cash without pre-emption rights.

## SEC filing metadata
- accession: 0001847903-25-000093
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000184790325000093/0001847903-25-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000184790325000093/cnta-20250620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001847903-25-000093
- JSON: https://secwatch.observer/filing/0001847903-25-000093.json
- Plain text: https://secwatch.observer/filing/0001847903-25-000093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.